Clinical Trial Update: T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing T-lymphocyte infusion versus standard therapy to prevent cytomegalovirus infection in patients after donor stem cell transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Graft-versus-host Disease

Drugs mentioned

• T-Lymphocyte Infusion

Snippet

Sponsor: University Hospital Birmingham | Conditions: Graft Versus Host Disease, Nonneoplastic Condition | Phase 2 | Status: UNKNOWN